missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 18622636

p57 Kip2 Antibody (SPM308), PerCP, Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals NBP2-47765PCP

Product Code. 18622636

  • € 544.00 / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

p57 Kip2 Monoclonal antibody specifically detects p57 Kip2 in Human, Mouse samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry (Paraffin), Immunofluorescence, CyTOF
TRUSTED_SUSTAINABILITY
Specifications

Specifications

p57 Kip2
Monoclonal
PerCP
Beckwith-Wiedemann syndrome, BWS, cyclin-dependent kinase inhibitor 1C, cyclin-dependent kinase inhibitor 1C (p57, Kip2), Cyclin-dependent kinase inhibitor p57, KIP2BWCR, p57, p57Kip2, WBS
Recombinant full-length human p57 Kip2 protein (Uniprot: P49918)
0.1 mL
Breast Cancer, Cancer, Cell Cycle and Replication, Core ESC Like Genes, DNA Repair, Stem Cell Markers
1028
Store at 4°C in the dark.
IgG2b κ
Flow Cytometry, Immunohistochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), Immunofluorescence
SPM308
PBS
Mouse
Protein A or G purified
RUO
Primary
Human, Mouse
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.